Agatolimod
N/A
Report date: 2025/03/28 20:01:04
NME
Base Information
Drug NameAgatolimod
Drug Alias Name +[11]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[27]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[34]
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesPfizer IncColey Pharmaceutical
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesColey Pharmaceutical Group IncNational Institutes Of HealthMasonic Cancer Center, University Of Minnesota +[16]
Active IndicationsN/A
Inactive Indications +[27]